Literature DB >> 16005882

Population-based assessment of subclinical coronary atherosclerosis using electron-beam computed tomography.

Axel Schmermund1, Stefan Möhlenkamp, Sina Berenbein, Heiko Pump, Susanne Moebus, Ulla Roggenbuck, Andreas Stang, Rainer Seibel, Dietrich Grönemeyer, Karl-Heinz Jöckel, Raimund Erbel.   

Abstract

AIMS: Coronary artery calcification (CAC) is determined as a measure of the extent of coronary atherosclerosis and can be used for expanded cardiovascular risk stratification. It was our aim to establish reference CAC scores in a population-based unselected European cohort. METHODS AND
RESULTS: The Heinz Nixdorf Recall study (HNR) recruited a total of 4814 participants aged 45-74 years. Cardiovascular risk factors and medications were recorded, and CAC was measured using electron-beam CT (EBCT). CAC score distribution was compared with previous studies in subjects who were self-referred, volunteered, or were physician-referred. Of the 4472 (92.9%) subjects free of clinical coronary artery disease, the CAC score was available in 4275 (95.3%) (2027 men, 2248 women). CAC scores were lower in particular in the higher age groups (> or = 60 years) in men than in the previous studies. Also, in most age groups (except the highest, 70-74 years), subjects with no cardiovascular medications had significantly lower CAC scores than subjects using cardiovascular medications.
CONCLUSIONS: The current report characterises the distribution of EBCT-derived CAC scores in a European unselected population. Compared with previous reports, CAC scores were lower in our cohort, in particular in subjects not receiving cardiovascular medications. Classification of the CAC score may underestimate true risk if previously published referral cohorts are used as the reference.

Entities:  

Mesh:

Year:  2005        PMID: 16005882     DOI: 10.1016/j.atherosclerosis.2005.06.003

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  33 in total

1.  Development of a new diabetes risk prediction tool for incident coronary heart disease events: the Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall Study.

Authors:  Joseph Yeboah; Raimund Erbel; Joseph Chris Delaney; Robin Nance; Mengye Guo; Alain G Bertoni; Matthew Budoff; Susanne Moebus; Karl-Heinz Jöckel; Gregory L Burke; Nathan D Wong; Nils Lehmann; David M Herrington; Stefan Möhlenkamp; Philip Greenland
Journal:  Atherosclerosis       Date:  2014-08-14       Impact factor: 5.162

Review 2.  Non-invasive screening for coronary artery disease: calcium scoring.

Authors:  Raimund Erbel; Stefan Möhlenkamp; Gert Kerkhoff; Thomas Budde; Axel Schmermund
Journal:  Heart       Date:  2007-12       Impact factor: 5.994

3.  B-type natriuretic peptide: distribution in the general population and the association with major cardiovascular and coronary events--the Heinz Nixdorf Recall Study.

Authors:  Kaffer Kara; Amir A Mahabadi; Marie H Geisel; Nils Lehmann; Hagen Kälsch; Marcus Bauer; Till Neumann; Nico Dragano; Susanne Moebus; Stefan Möhlenkamp; Karl-Heinz Jöckel; Raimund Erbel
Journal:  Clin Res Cardiol       Date:  2013-10-15       Impact factor: 5.460

Review 4.  Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification.

Authors:  Sophie E P New; Elena Aikawa
Journal:  Circ Res       Date:  2011-05-27       Impact factor: 17.367

5.  Poor social relations and adverse health behaviour: stronger associations in low socioeconomic groups?

Authors:  Simone Weyers; Nico Dragano; Susanne Möbus; Eva-Maria Beck; Andreas Stang; Stephan Möhlenkamp; Karl Heinz Jöckel; Raimund Erbel; Johannes Siegrist
Journal:  Int J Public Health       Date:  2009-09-23       Impact factor: 3.380

6.  Association of coronary artery calcium and congestive heart failure in the general population: Results of the Heinz Nixdorf Recall study.

Authors:  H Kälsch; N Lehmann; S Möhlenkamp; T Neumann; U Slomiany; Axel Schmermund; Andreas Stang; S Moebus; M Bauer; K Mann; K-H Jöckel; R Erbel
Journal:  Clin Res Cardiol       Date:  2010-03       Impact factor: 5.460

7.  Comparison of factors associated with carotid intima-media thickness in the Multi-ethnic Study of Atherosclerosis (MESA) and the Heinz Nixdorf Recall Study (HNR).

Authors:  Marcus Bauer; Joseph A C Delaney; Stefan Möhlenkamp; Karl-Heinz Jöckel; Richard A Kronmal; Nils Lehmann; Kenneth J Mukamal; Susanne Moebus; Joseph F Polak; Nico Dragano; Matthew J Budoff; Raimund Erbel; Robyn L McClelland
Journal:  J Am Soc Echocardiogr       Date:  2013-04-20       Impact factor: 5.251

8.  Association of exercise capacity and the heart rate profile during exercise stress testing with subclinical coronary atherosclerosis: data from the Heinz Nixdorf Recall study.

Authors:  Stefan Möhlenkamp; Nils Lehmann; Axel Schmermund; Ulla Roggenbuck; Susanne Moebus; Nico Dragano; Marcus Bauer; Hagen Kälsch; Barbara Hoffmann; Andreas Stang; Martina Bröcker-Preuss; Michael Böhm; Klaus Mann; Karl-Heinz Jöckel; Raimund Erbel
Journal:  Clin Res Cardiol       Date:  2009-08-20       Impact factor: 5.460

9.  Cardiovascular risk factors and signs of subclinical atherosclerosis in the Heinz Nixdorf Recall Study.

Authors:  Raimund Erbel; Stefan Möhlenkamp; Karl-Heinz Jöckel; Nils Lehmann; Susanne Moebus; Barbara Hoffmann; Axel Schmermund; Andreas Stang; Johannes Siegrist; Nico Dragano; Dietrich Grönemeyer; Rainer Seibel; Klaus Mann; Martina Bröcker-Preuss; Knut Kröger; Lothar Volbracht
Journal:  Dtsch Arztebl Int       Date:  2008-01-07       Impact factor: 5.594

Review 10.  Exercise therapy in type 2 diabetes.

Authors:  Stephan F E Praet; Luc J C van Loon
Journal:  Acta Diabetol       Date:  2009-05-29       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.